West Virginia University College of Law Professor Sean Tu was recently interviewed by MedPage Today. In the interview, Professor Tu discusses the methods that pharmaceutical companies use to monopolize the prescription drug market such as evergreening, patent thicketing, and product topping.  The interview was published online on February 3, 2023.

Professor Tu has recently published on the topic in the New England Journal of Medicine: A “Method of Use” to Prevent Generic and Biosimilar Market Entry. This article was published online by the journal on January 25, 2023 in print in volume 388.

West Virginia College of Law professor S. Sean Tu recently published new scholarship in the New England Journal of Medicine. The article is titled A "Method of Use" to Prevent Generic and Biosimilar Market Entry. Professor Tu co-authored the article with Ameet Sarpatwari, Ph.D., J.D., a colleague at the Program On Regulation, Therapeutics, And Law (PORTAL) at Harvard Medical School where Professor Tu is a visiting professor.  It was published online by the journal on January 25, 2023 and will subsequently appear in print in volume 388 on February 9, 2023.

Find more of Professor Tu's scholarship on SSRN.

West Virginia College of Law professor  S. Sean Tu recently published new opinion piece in JAMA. The article, titled  "Recent Patent Reform Bills and Their Implications for Prescription Drugs," is co-authored by Professor Tu with researchers at Program On Regulation, Therapeutics, And Law (PORTAL) at Harvard Medical School where Professor Tu is a visiting professor.  It was published online by the journal on January 13, 2023.

The article discusses three bills expected to be re-introduced in Congress this session with implication for intellectual property law: the Patent Eligibility Restoration Act of 2022 (S. 4734), the Interagency Patent Coordination and Improvement Act of 2022 (S. 4430), and the Patent Examination and Quality Improvement Act of 2022 (S. 4704). 

West Virginia University College of Law professor S. Sean Tu recently published new scholarship in IDEA: The Law Review of the Franklin Pierce Center for IP. The article is titled "Antibody Claims and the Evolution of the Written Description / Enablement Requirement" and appeared in volume 63, issue 1 of the journal in January 2023. Professor Tu co-authored the article with Christopher M. Holman of the University of Missouri-Kansas City School of Law.

From the abstract:

West Virginia College of Law professor S. Sean Tu recently published new scholarship in  JAMA Internal Medicine. The article, titled "Frequency of Approval and Marketing of Biosimilars With a Skinny Label and Associated Medicare Savings" is co-authored by Professor Tu with researchers at Program On Regulation, Therapeutics, And Law (PORTAL) at Harvard Medical School where Professor Tu is a visiting professor.  It was published online by the journal on November 28, 2022.

The journal editors simultaneously published an Editor's Note highlighting the importance and impact of the issues addressed by Professor Tu and co-authors in their article: "Savings Associated With “Skinny Label” Biosimilars."